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Leuven, Belgium
Objectives We compared biological repair after acute myocardial infarction (AMI) with selected porcine progenitor cell
populations.
Background Cell types and mechanisms responsible for myocardial repair after AMI remain uncertain.
Methods In a blinded, randomized study, we infused autologous late-outgrowth endothelial progenitor cells (EPC) (n  10,
34  22  106 CD29-31-positive, capable of tube formation), allogeneic green fluorescent peptide–labeled
mesenchymal stem cells (MSC) (n  11, 10  2  106 CD29-44-90-positive, capable of adipogenic and osteo-
genic differentiation), or vehicle (CON) (n  12) in the circumflex artery 1 week after AMI. Systolic function (ejec-
tion fraction), left ventricular (LV) end-diastolic and end-systolic volumes, and infarct size were assessed with
magnetic resonance imaging at 1 week and 7 weeks. Cell engraftment and vascular density were evaluated on
postmortem sections.
Results Recovery of LV ejection fraction from 1 to 7 weeks was similar between groups, but LV remodeling markedly
differed with a greater increase of LV end-systolic volume in MSC and CON (11  12 ml/m2 and 7  8
ml/m2 vs. 3  11 ml/m2 in EPC, respectively, p  0.04), and a similar trend was noted for LV end-diastolic
volume (p  0.09). After EPC, infarct size decreased more in segments with 50% infarct transmurality (p 
0.02 vs. MSC and CON) and was associated with a greater vascular density (p  0.01). Late outgrowth EPCs se-
crete higher levels of the pro-angiogenic placental growth factor (733 [277 to 1,214] pg/106 vs. 59 [34 to 88]
pg/106 cells in MSC, p  0.03) and incorporate in neovessels in vivo.
Conclusions Infusion of late-outgrowth EPCs after AMI improves myocardial infarction remodeling via enhanced neovascular-
ization but does not mediate cardiomyogenesis. Endothelial progenitor cell transfer might hold promise for heart
failure prevention via pro-angiogenic or paracrine matrix-modulating effects. (J Am Coll Cardiol 2010;55:
2232–43) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.081m
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rom the *Division of Cardiology, Department of Cardiovascular Diseases, and the
epartments of †Radiology, ‡Nuclear Medicine, and §Medical Diagnostic Sciences,
asthuisberg University Hospitals Leuven, Leuven, Belgium; Vesalius Research
enter, Flanders Institute for Biotechnology (VIB); and the Departments of
Molecular Medicine and #Public Health, Biostatistical Center, KU-Leuven, Leu-
en, Belgium. This work was supported by grants of the Fund for Scientific aononuclear progenitor cells in mice (1) has gained signif-
cant momentum, but studies in patients with acute myo-
ardial infarction (AMI) have shown mixed results (2–4). In
esearch–Flanders G.0442.06 and G.0280.05, VIB (Dr. Janssens) and the Research
und KU-Leuven GOA/2007/13 (Drs. Janssens and Pokreisz). Dr. Janssens is holder
f a chair supported by AstraZeneca. Dr. Dépelteau was supported by a fellowship,
unded by the Royal College of Physicians and Surgeons of Canada.Manuscript received May 29, 2009; revised manuscript received October 5, 2009,
ccepted October 5, 2009.
m
(
n
e
T
t
p
c
o
i
o
p
l
c
w
i
o
g
M
S
U
A
o
n
b
n
a
w
u
s
C
L
f
(
w
E
w
e
h
i
A
c
w
G
p
a
E
c
i
s
fl
I
A
r
(
b
T
w
a
t
P
M
i
(
a
c
t
t
w
t
g
o
f
f
e
1
i
I
d
(
w
w
d
w
a
I
d
t
(
a
o
u
A
u
m
p
w
v
a
m
a
A
f
c
s
2233JACC Vol. 55, No. 20, 2010 Dubois et al.
May 18, 2010:2232–43 Progenitor Cell Repair After Myocardial Infarctionost randomized studies a heterogeneous mononuclear cell
MNC) population was infused in the infarct-related coro-
ary artery (IRA), and change in global ejection fraction was
valuated as a surrogate primary efficacy end point.
See page 2254
here is a growing recognition that indirect paracrine
rophic effects rather than cardiomyogenesis resulting from
rogenitor cell transdifferentiation mediate the observed
hanges in contractile function or infarct size after infusion
f a mixed MNC population (5). Although critically
mportant variables, including doses and delivery routes
f labeled mixed mononuclear or mesenchymal (MSC)
rogenitor cells, have been investigated in representative
arge animal models (6–10), direct comparison of selected
ell populations has received limited attention. Therefore
e compared functional and structural recovery after AMI
n pigs after intracoronary (IC) infusion of autologous late
utgrowth endothelial progenitor cells (EPCs) versus allo-
eneic MSCs.
ethods
tudy design. The Animal Care and Use Committee of
niversity of Leuven approved this study. At 1 week after
MI, pigs were randomly assigned to blinded IC delivery
f control medium (CON), autologous EPCs, or alloge-
eic MSCs. Hemodynamic variables were measured at
aseline and after 1 week and 7 weeks. Magnetic reso-
ance imaging (MRI) was performed at 1 week and 7 weeks
fter AMI in a subgroup of pigs. All pigs were killed at 7
eeks. Growth-related changes in myocardial mass and vol-
mes were evaluated in a separate series of healthy pigs over the
ame time period.
ell preparation. ISOLATION AND CULTURE OF AUTOLOGOUS
ATE-OUTGROWTH EPCs. Mononuclear cells were isolated
rom 40 ml blood by Lymphoprep density centrifugation
Axis-Shield, Oslo, Norway) and 50 to 100  106 MNCs
ere plated on fibronectin-coated (5 g/ml) dishes in
BM2 (Clonetics, San Diego, California), supplemented
ith 5% FBS (Invitrogen, Carlsbad, California), vascular
ndothelial growth factor, human epidermal growth factor,
uman basic fibroblast growth factor, ascorbic acid, R3-
nsulin-like growth factor-1, and gentamycin/amphotericin-B.
fter 4 days, nonadherent cells were removed and cells were
ultured for an additional 3 weeks. Late-outgrowth EPCs
ere then incubated for 24 h with iron oxide (Endorem,
uerbet, France) and poly-L-lysine (Sigma) and diluted in
hosphate-buffered saline for phenotypic characterization
nd IC delivery. Alternatively, for biodistribution studies,
PCs were genetically labeled with a lentiviral reporter
onstruct (p24 titer 5.5  106 pg/ml, 1/150 dilution) express-
ng nuclear targeted beta-galactosidase (LacZ). Expression of
urface markers was performed by immunofluorescence and
ow cytometry (CD31, CD45, CD29, and SLA DR). (SOLATION AND CULTURE OF
LLOGENEIC MSCs. Bone mar-
ow was aspirated from the femur
10 ml), diluted in phosphate-
uffered saline, 1:3, and filtered.
he MNC fraction was isolated
ith Lymphoprep (Axis-Shield)
nd amplified in adherent cell cul-
ures (0.1% gelatine-coating).
henotypic characterization of
SCs was performed by evaluat-
ng expression of surface markers
CD31, CD90, CD29, CD44,
nd CD45), and plasticity was
onfirmed with adipogenic and os-
eogenic differentiation (stem cell
echnology) (11,12). The MSCs
ere genetically labeled with len-
iviral vectors encoding enhanced
reen fluorescent peptide (GFP)
r nuclear targeted LacZ gene
or biodistribution studies. The
unctional titer of the GFP-
xpressing lentiviral vector was
.75  107 U/ml; multiplicity of
nfection was 14.
nduction of AMI and hemo-
ynamic measurements. Pigs
20 to 30 kg) were pre-treated
ith 400 mg amiodarone for 1
eek and with aspirin and clopi-
ogrel 1 day before AMI. Pigs
ere pre-anesthetized with ket-
mine hydrochloride (20 mg/kg,
M) (Anesketin, Eurovet, Heus-
en, Belgium), followed by con-
inuous infusion of propofol
0.15 mg/kg/min, IV), intubated
nd ventilated with a 1:1 mixture
f air and oxygen and anticoag-
lated (10,000 IU heparin). The
MI was induced under contin-
ous electrocardiographic (ECG)
onitoring by stenting and 90-min balloon occlusion of the
roximal circumflex artery, followed by reperfusion. One
eek later, control medium, EPC, or MSC were injected
ia a perfusion catheter inflated in the stented circumflex
rtery segment during a 10-min stop-flow condition. Im-
ediately after cell transfer and before pigs were killed,
ngiography of the IRA was repeated to confirm patency.
spirin (100 mg) and clopidogrel (75 mg) were given daily
or 7 weeks.
Hemodynamic variables were measured with a 7-F Millar
atheter positioned in the left ventricle (LV). Heart rate, LV
ystolic and diastolic pressures, and first derivatives thereof
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
CON  vehicle, control
medium
ECG  electrocardiographic
EDV  end-diastolic volume
EPC  endothelial
progenitor cell
ESV  end-systolic volume
GFP  green fluorescent
peptide
IC  intracoronary
IGF  insulin-like growth
factor
IRA  infarct related artery
LacZ  beta-galactosidase
LV  left ventricle/
ventricular
LVEDV  left ventricular
end-diastolic volume
LVESV  left ventricular
end-systolic volume
MMP  matrix
metalloproteinase
MNC  mononuclear cell
MRI  magnetic resonance
imaging
MSC  mesenchymal stem
cell
PLGF  placental growth
factor
qPCR  quantitative
polymerase chain reaction
TGF  transforming growth
factor
TTC  2,3,5-
triphenyltetrazoliumchloride
VEGF  vascular
endothelial growth factordP/dtmax/min) were recorded at baseline, before cell transfer,
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Progenitor Cell Repair After Myocardial Infarction May 18, 2010:2232–43nd before pigs were killed and processed with Powerlab
oftware (AD Instruments, Oxfordshire, United Kingdom).
RI: cine-angiography, delayed enhancement infarct,
nd perfusion studies. Cardiac MRI (1.5-T, Sonata, Sie-
ens, Erlangen, Germany) was performed at 1 week and 7
eeks after AMI. All studies were done with Siemens
umaris-4 software, ECG triggering, and cardiac-
edicated surface coils. Global function was assessed with
reath-hold cine MRI in short axis, vertical axis, and
orizontal long axis. In short axis, the LV was completely
ncompassed by contiguous 6-mm-thick slices. Infarct area
as defined as the zone of bright signal on late-enhanced
mages (i.e., 10 to 20 min after injection of 0.15 mmol/kg of
adopentetate dimeglumine), with an inversion-recovery
radient-echo technique. All MRI studies with assessment
f global LV function (left ventricular end-diastolic volume
LVEDV] and left ventricular end-systolic volume
LVESV]) and calculation of infarct volume were ana-
yzed on an offline workstation (ARGUS, Siemens) by inves-
igators unaware of treatment allocation (2). We used the 16
egments model to grade transmural extent of late hyperen-
ancement and reported transmurality estimates at 7-week
ollow-up for segments with a mean baseline hyperenhance-
ent of 10%, 25%, 50%, 75%, and 90% (13,14). First-pass
erfusion imaging after bolus injections of gadopentetate
imeglumine (0.05 mmol/kg, 3.5 cc/s) was performed for 1
in, obtaining 80 measurements (0.8 s temporal resolution)
ith ECG-gated steady state free precession imaging pulse
equence in short-axis direction. Relative upslope was
alculated for segments 5-6-11-12, reflecting the circum-
ex artery perfusion area (15,16).
Figure 1 Schematic Presentation of Study Flow
Of a total of 44 infarcted pigs, 41 underwent cell transfer at 1 week, and 33 survi
related changes in myocardial mass and volumes were evaluated in 8 healthy pigs
MSC  mesenchymal stem cell; Tx  transfer.mmunohistochemical, reverse-transcription polymerase
hain reaction analysis of myocardial biopsies, and
olecular profiling of progenitor cells. At week 7,
iopsies were taken from 1-cm-thick transverse sections
rom infarct core, border zone, and remote areas and stored
n 10% formalin or flash frozen in liquid nitrogen. Adjacent
yocardial transsections were stained with 1% 2,3,5-
riphenyltetrazoliumchloride (TTC) for 10 min to delineate
nfarct borders. The GFP and Prussian blue stainings were
erformed to detect labeled MSCs and EPCs, respectively.
o confirm GFP expression, 10- to 30-m frozen sections
ere analyzed with dual photon laser microscopy equipped
ith spectral analysis detector (Zeiss LSM 510 Meta, Carl
eiss, Oberkochen, Germany). Isolated GFP-infected bone
arrow cells served as positive control. Vascular density was
lindly assessed on 5-m-thick sections by counting
solectin-B4-stained (L5391, Sigma) vessels in 5 high-
ower fields in infarct core and border zones and in remote
yocardium in 9 pigs/group. We blindly investigated the
resence of dense (Type I) and loosely assembled (Type III)
ollagen with circularly polarized light on randomly selected
irius red-stained sections from the infarct border zone of
ON, EPC, and MSC. Expression of genes involved in LV
emodeling, neovascularization, and apoptosis was mea-
ured with quantitative polymerase chain reaction (qPCR)
n extracts from these areas (Online Table 1).
In addition, we studied LacZ-labeled EPC and MSC
ngraftment and survival in the infarcted myocardium at 7
eeks and biodistribution to remote organs at 1 week.
ifferent zones in the heart, lung, liver, kidney, spleen, and
7 weeks; 23 pigs underwent serial magnetic resonance imaging (MRI). Growth-
 acute myocardial infarction; CON  vehicle; EPC  endothelial progenitor cell;ved at
. AMI
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May 18, 2010:2232–43 Progenitor Cell Repair After Myocardial Infarctionrain were sampled for histochemical LacZ staining and
PCR analysis of labeled cells.
Transcript levels of genes encoding growth factors were
nalyzed in 3 independent cultures of EPCs and MSCs,
hereas secretome in conditioned medium from cultured
PCs and MSCs was analyzed in 4 independent experi-
Figure 2 Phenotypic Analysis and Labeling of Progenitor Cells
Flow cytometry of EPC and MSC (A, B) and representative examples of culture-exp
are shown (F, G). Progenitor cell function was confirmed by tube formation on mat
confirmed by osteogenic differentiation on Alizarin stain (H) and adipogenic differeents with enzyme-linked immunoadsorbent assay for fi-
roblast growth factor-2, vascular endothelial growth factor
VEGF), insulin-like growth factor (IGF)-1, transforming
rowth factor beta-1 (R&D Systems, Minneapolis, Minne-
ota), and placental growth factor (PLGF) (Thrombogen-
cs, Leuven, Belgium).
ro
autologous unlabeled (C) and Endorem-labeled EPCs (D) and allogeneic MSCs
E). The MSCs (F) were green fluorescent peptide-labeled (G), and plasticity was
n on oil-red stain (I). Abbreviations as in Figure 1.In Vit
anded
rigel (
ntiatio
S
v
f
t
a
c
m
m
R
i
a
p
a
t
i
w
v
t
T
a
p
N
R
S
p
a
(
p
w
s
i
a
a
t
L
P
p
f
m
C
a
a
(
n
i
a
a
o
g
(
E
a
m
l
H
7
L
a
m
1
M
s
3
d
m
N
E
c
7
w
f
l
C
P
c
O
i
p
s
s
(
m
I
i
T
V
h
m
T
e
2236 Dubois et al. JACC Vol. 55, No. 20, 2010
Progenitor Cell Repair After Myocardial Infarction May 18, 2010:2232–43tatistical analysis. Hemodynamic and MRI data and
ascular density are presented as mean and SD, and changes
rom baseline to 7 weeks were analyzed with Kruskal-Wallis
ests. Transcriptome and secretome data in EPC and MSC
re presented as median, minimum, and maximum and
ompared with Mann-Whitney U tests. Differences in
atrix gene expression and vascular density between treat-
ent groups were analyzed with Kruskal-Wallis tests.
elative upslope in circumflex artery perfused segments and
nfarct transmurality were compared with analysis of vari-
nce for repeated measures. In this model, we adjusted for
ossible correlations among all segments by taking into
ccount the distance between 2 segments. We assumed that
hese correlations decreased exponentially as the distance
ncreased between the segments. All treatment differences
ere estimated and presented with 95% confidence inter-
als. To account for multiple pairwise comparisons between
reatment groups, significance level was adjusted with
ukey’s method. All statistical tests were 2-sided and
ssessed at the 5% significance level. All analyses were
erformed with SAS (version 9.2, SAS Institute, Cary,
orth Carolina).
esults
tudy group. Of 52 pigs, we infarcted 44 pigs and com-
leted invasive hemodynamic assessment at 7 weeks in 33
nimals (12 CON, 10 EPC, 11 MSC) (Fig. 1). Of these, 23
7 CON, 9 EPC, 7 MSC) underwent serial MRI. Three
igs died during induction of AMI (before allocation),
hereas after allocation 4 died in CON (1 pneumonia, 1
epsis, 1 ischemic cardiomyopathy, and 1 unknown), 2 died
n EPC (1 air embolism during cell transfer, 1 unknown),
nd 2 died in MSC (1 infection, 1 unknown). Eight
dditional pigs were serially scanned at 1 week and 7 weeks
o account for growth- and biological age-related changes in
V volumes and mass.
henotypic and functional analysis of labeled porcine
rogenitor cells. Flow cytometry of EPCs revealed uni-
orm expression of CD29 and CD31 but not the monocytic
arker CD45, whereas MSCs expressed CD29, CD44, and
D90 (Fig. 2). The MSCs displayed a typical spindle-shape
ppearance with a 80% transfection efficiency for GFP
nd retained plasticity after multiple passages and labeling
Figs. 2H and 2I). Late outgrowth EPCs induced vascular
etwork formation on matrigel (Fig. 2E).
Transcriptome analysis of cultured EPCs and MSCs
ndicated a trend toward higher expression levels of
ngiopoietin-1, hepatocyte growth factor, IGF-1, IGF-2,
nd VEGF-A in MSCs (which was not affected by GFP
verexpression, data not shown), whereas platelet-derived
rowth factor-beta was predominantly expressed in EPCs
Table 1). Secretome analysis of conditioned medium from
PCs showed significantly higher levels of the pro-ngiogenic protein PLGF (p  0.03), whereas conditioned Cedium from MSCs contained higher VEGF and IGF-1
evels (p  0.05) (Table 2).
emodynamic and MRI measurements at 1 week and
weeks after AMI. HEMODYNAMIC MEASUREMENTS AND
ABORATORY FINDINGS. Rate-pressure product 7 weeks
fter AMI did not differ between groups (7,689  1,967
m Hg/min; 6,441  1,740 mm Hg/min; and 6,538 
,087 mm Hg/min in CON [n  12], EPC [n  10], and
SC [n 11]). No significant differences were observed in
ystolic or diastolic function at 7 weeks (dP/dtmax/IP:
0 6 s–1 in CON, 33 6 s–1 in EPC, 32 6 s–1 in MSC;
P/dtmin: 1,554  663 mm Hg/s in CON, 1,212  386
m Hg/s in EPC, 1,304  266 mm Hg/s in MSC, p 
S for all).
On the basis of prior dose-finding studies, 34 22 106
PC and 10  2  106 MSC were injected in the
ircumflex artery. Cell or placebo transfer was performed at
 1 days after AMI for all groups, and pigs were killed 6
eeks later. Hematological values and liver and renal
unction tests at 1 week and 7 weeks were within normal
imits (data not shown).
INE-ANGIOGRAPHY, DELAYED ENHANCEMENT, AND
ERFUSION STUDIES USING MRI. In 2 pigs (both EPC),
ineMRI could not be analyzed due to triggering artefacts.
ne week after AMI, LV ejection fraction equally and signif-
cantly decreased in all groups compared with values in healthy
igs. Six weeks later, ejection fraction showed a modest and
imilar increase in the 3 groups (Table 3); in contrast, LVESV
ignificantly increased in CON and MSC but not in EPC
Online Fig. 1A, Table 3) (p  0.04). A similar trend was
easured for LVEDV (Online Fig. 1B, Table 3) (p  0.09).
mportantly, in 8 uninstrumented sham animals, body weight
ncreased by 127% versus 90%, 100%, and 101% in infarcted
ranscriptional Analysis of EPC and MSCTable 1 Transcriptional Analysis of EPC and MSC
EPC 2deltaCt
(n  3)
MSC 2deltaCt
(n  3)
Mann-Whitney
U Test
ANGPT-1 0.0004 (0.0002–0.02) 0.43 (0.14–0.64) p 0.1
ANGPT-2 2.45 (0.28–2.53) 0.23 (0.19–0.31) p 0.2
FGF-2 1.53 (0.39–7.81) 1.80 (0.17–2.16) p 1.0
HGF 0.001 (0.0005–0.02) 0.23 (0.13–0.39) p 0.1
HIF-1a 4.93 (3.22–12.77) 7.97 (4.87–10.09) p 1.0
IGF-1 0.04 (0.0005–0.08) 1.66 (0.12–2.20) p 0.1
IGF-2 0.002 (0–0.01) 0.77 (0.19–2.28) p 0.1
PDGF-a 0.018 (0.017–0.05) 0.03 (0.02–0.05) p 0.4
PDGF-b 1.24 (0.19–1.55) 0.0006 (0.0002–0.005) p 0.1
SDF-1 0.002 (0.00001–0.005) 0.03 (0.00001–0.11) p 0.4
TGF-1 0.83 (0.62–2.81) 0.98 (0.41–1.25) p 1.0
VEGF-A 0.17 (0.06–0.42) 1.24 (1.06–1.70) p 0.1
VEGF-R2 0.25 (0.004–0.44) 0 (0–0.05) p 0.2
alues are presented as median (minimum to maximum); n indicates the number of cell cultures.
ANGPT angiopoietin; EPC endothelial progenitor cell; FGF fibroblast growth factor; HGF
epatocyte growth factor; HIF  hypoxia-inducible factor; IGF  insulin-like growth factor; MSC 
esenchymal stem cell; PDGF platelet-derived growth factor; SDF stromal cell derived factor;
GF  transforming growth factor; VEGF  vascular endothelial growth factor; VEGF-R  vascular
nothelial growth factor receptor.ON, EPC, and MSC pigs, respectively. The concomitant,
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May 18, 2010:2232–43 Progenitor Cell Repair After Myocardial Infarctionge-related increase in LVESV was 3  8 ml/m2 (4%) in
ham pigs but more than 2-fold higher after AMI in CON and
SC pigs (but not in EPC-treated pigs). Similarly, LVEDV
ncreased by 15  12 ml/m2 with age in sham pigs (26%),
hich again was further accentuated after AMI in CON and
SC but not in EPC pigs (31% and 46% vs. 7%,
espectively). Taken together, LV dilation in CON and MSC
ut not in EPC-treated pigs exceeds volume changes related to
ormal growth and aging.
No differences in initial infarct size were measured before
ell transfer (Table 3), but the pattern of infarct remodeling
as strikingly different, with a significant EPC treatment
ffect on infarct transmurality in the worst affected segments
overall p  0.02 for segments with transmurality 50%, p 
.005 for segments with transmurality 75%, and p 
.003 for segments with 90% infarct transmurality) (On-
ine Fig. 2). Myocardial perfusion, assessed in the area at
isk (segments 5-6-11-12) during first-pass perfusion im-
ging, showed a trend for a greater relative upslope in EPC
72% [2 to 119]) as compared with CON (25% [33 to
36]) and MSC (2% [28 to 84]).
istological analysis. PROGENITOR CELL ENGRAFTMENT/
URVIVAL. Immunohistochemical analysis with GFP anti-
era and confocal analysis to detect labeled MSCs in the
nfarcted heart (Fig. 3A) suggested the presence of GFP-
ositive cells in the infarct border zones These cells were
lso immunoreactive for desmin, as demonstrated on 5-m
djacent sections (Figs. 3B and 3C). However, dual photon
icroscopy with spectral analysis failed to confirm the
haracteristic GFP emission spectrum at 509 nm in these
reas (Figs. 3D to 3G), qPCR analysis failed to amplify
FP-transcripts in the border or infarct area from all 11
ecretome of EPC and MSCTable 2 Secretome of EPC and MSC
EPC
(n  4)
MSC
(n  4)
Mann-Whitney
U Test
FGF-2 (pg/106) 17.0 (5.2–97.4) 7.1 (4.1–7.6) p 0.20
VEGF (pg/106) 29.4 (24.7–84.2) 424.1 (160.8–849.4) p 0.05
PLGF (pg/106) 732.5 (277.3–1214) 58.6 (33.8–87.9) p 0.03
IGF1 (pg/10
6) 12.8 (8.9–49.5) 595.1 (125.6–997.6) p 0.02
TGF1 (pg/10
6) 44.0 (11.8–105.2) 54.1 (24.6–109.9) p 0.69
alues are presented as median (minimum to maximum); n indicates the number of experiments.
PLGF  placental growth factor; other abbreviations as in Table 1.
RI Data at 1 Week and 7 Weeks After AMITable 3 MRI Data at 1 eek and 7 Weeks After AMI
CON (n  7)
Week 1 Week 7 Change Week 1
LVEDVi (ml/m
2) 64 19 81 17 17 12 74 20
LVESVi (ml/m
2) 35 13 42 14 7 8 43 16
EF (%) 46 8 48 7 3 6 44 10
Infarct size (%) 15 4 9 4 6 4 17 7
nfarct size is expressed as percentage of total myocardial mass. Values are presented as mean 
AMI  acute myocardial infarction; EF  ejection fraction; LVEDV  left ventricular end-diastolic vol
bbreviations as in Table 1.igs, and immunoblot analysis with GFP-specific antisera
id not reveal GFP immunoreactivity (data not shown).
russian blue staining of sections from the infarct core and
order zone of EPC-treated animals indicated focal areas
ith small vessels that contained feridex-labeled cells, which
ere immunoreactive for lectin (Figs. 3H to 3J). In the pigs
ho underwent cell transfer with LacZ-labeled EPC and
SC, LacZ histochemical staining of sections from the
nfarct core and border zone 6 weeks after cell transfer
howed incorporation of labeled EPCs (Figs. 3K and 3L)
ut not MSCs. Labeled EPCs co-expressed von Willebrand
actor (Fig. 3M) and were lining neovessels with smooth
uscle actin-positive cells in the media (Fig. 3N), hence,
hey were capable of supporting blood flow. The qPCR
nalysis confirmed high LacZ transcript levels confined to
he ischemic myocardium (data not shown). Histochemical
nalysis of labeled cells in remote organs did not find
vidence for cell homing in other organs, other than for EPCs
n splenic sinusoids, intersinusoidal red pulp around cords of
illroth, and endothelium of splenic venules (Figs. 4A and
C). In the lung (Figs. 4E to 4H), LacZ expression was
onfined to the alveolar parenchyma of MSC-treated pigs
Fig. 4F). Taken together, these data suggest that allo-
eneic MSCs failed to permanently engraft, proliferate,
r transdifferentiate in the ischemic territory after IC
njection 6 weeks after AMI, whereas late-outgrowth
PCs participate in neovascularization.
ASCULAR DENSITY IN INFARCT CORE AND BORDER
ONE. To evaluate whether changes in infarct remodeling and
erfusion were associated with enhanced neovascularization,
ascular density was determined on lectin-stained sections
rom the infarct core, border zone, and remote myocardium
Fig. 5). No differences were seen between groups in the infarct
ore or remote myocardium. However, in the border zone,
ascular density was significantly higher in EPC rather than in
ON and MSC (p 0.01). Representative examples from the
nfarct border zone of CON, EPC, and MSC show 15%, 34%,
nd 20% capillaries over total number of cells/high-power field,
espectively. Interestingly, a trend toward higher expression
evels of the anti-apoptotic BCL-XL gene was seen in
PC rather than in CON and MSC, most likely attrib-
n  7) MSC (n  7)
p Valuek 7 Change Week 1 Week 7 Change
24 2 18 65 20 85 22 20 15 0.09
16 3 11 37 12 48 16 11 12 0.04
8 5 11 44 5 45 7 2 11 0.64
n  9)
 5 8 8 16 9 7 1 8 9 0.84
values indicate differences among 3 groups (Kruskal-Wallis).EPC (
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9
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Progenitor Cell Repair After Myocardial Infarction May 18, 2010:2232–43table to paracrine trophic effects of EPCs on cardiomy-
cytes at risk in the border zone (Online Table 2).
XTRACELLULAR MATRIX DEGRADATION AND VENTRICULAR
EMODELING. Infarct patterns are shown on representa-
ive TTC stains from the 3 groups (Figs. 6A to 6C).
uantitative PCR analysis in the infarct border zone
howed that matrix metalloproteinase (MMP)-2 is the
ost abundantly expressed metalloproteinase in the in-
arcted porcine heart. Its expression was significantly
educed in EPC-treated pigs compared with MSC and
Figure 3 Histological Analysis of Progenitor Cell Engraftment in
At 7 weeks, transverse sections of the heart stained with 2,3,5-triphenyltetrazolium
staining with desmin (B) and green fluorescent peptide (GFP) antisera (C) in borde
were also immunoreactive for desmin, as demonstrated on 5-m adjacent section
the characteristic 509-nm GFP-emission amplitude in myocardial tissue sections, w
infected bone marrow cells (positive controls) (F, G). Prussian blue staining of sec
areas of small vessels containing Endorem-labeled cells (arrows, I), which are rea
transfer of beta-galactosidase–labeled EPCs (K), beta-galactosidase histochemica
(arrows, L), which were also immunoreactive for von Willebrand factor (arrows, M) anON (Online Fig. 3). Transcript levels of the other rMPs and thrombospondin-1 did not differ between
roups. These findings were associated with less-
ronounced MMP-2 immunoreactivity in the infarct
order zone of EPC-treated pigs (Figs. 6D to 6F). Sirius
ed staining (Figs. 6G to 6I) and polarized light micros-
opy of the infarct border zone (Figs. 6J to 6L) showed a
etter organized scar in EPC than in CON and MSC.
inally, a trend toward reduced porcine brain natriuretic
eptide and porcine atrial natriuretic peptide transcript
evels in the infarct border zone was detected in EPC-
reated animals, consistent with the observed changes in
Infarcted Myocardium
ide show infarct core, border zone, and remote area (A). Immunohistochemical
of pigs treated with enhanced GFP-transduced MSCs. The GFP-positive cells
ws). Dual photon laser microscopy (D) with spectral analysis (E) failed to show
s the characteristic GFP emission wavelength was clearly present in lenti-GFP
from infarct border zone (arrowheads) of EPC (H) (desmin staining) showed focal
o lectin staining on 5-m adjacent sections (arrows, J). Six weeks after cell
ing of sections from the infarct border zone showed incorporation in neovessels
oth muscle actin in the media (arrowheads, N). Abbreviations as in Figure 1.the
chlor
r zone
s (arro
herea
tions
ctive t
l stain
d smoemodeling (Online Table 2).
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May 18, 2010:2232–43 Progenitor Cell Repair After Myocardial InfarctionFigure 4 Biodistribution of Labeled MSC and EPCs After Intracoronary Injection
Localization of beta-galactosidase (LacZ) labeled (blue) EPCs (A, C, E, G, I, J) and MSCs (B, D, F, H, K, L) in extracardiac tissues 1 week after delivery. After LacZ stain-
ing, histologic sections were stained with alpha-smooth muscle actin antisera (brown) and counterstained with nuclear fast red. In the spleen (A to D), strong LacZ
expression was confined to the sinusoids (arrowheads), intersinusoidal red pulp around cords of Billroth, and endothelium of venules (arrows) in EPC-treated pigs. The
LacZ expression was absent in splenic arterioles and surrounding lymphoid white pulp (asterisks) or trabecular meshwork (brown) of EPC- and MSC-treated pigs. In
lungs (E to H), LacZ expression was only detected in alveolar parenchyma of MSC-treated pigs (F, arrows and inset) but not in EPC pigs (E). No LacZ expression was
detected in bronchioles or peri-bronchiolar lung tissue (G, H), liver (I, K), or kidney (J, L). Abbreviations as in Figure 1.
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n this study we report that IC infusion of autologous
ate-outgrowth EPCs 1 week after AMI does not enhance
V global function recovery but prevents LV volume
xpansion as measured by MRI at 7-week follow-up. In pigs
andomized to allogeneic MSCs or CON, LV remodeling
fter myocardial infarction was characterized by marked
SV and EDV expansion (Online Fig. 1, Table 3), which
xceeded natural growth-related increase greater than 2-fold
ver the same period. Transfer of late-outgrowth EPCs was
ssociated with better infarct remodeling, as evidenced by
maller transmural extent of delayed enhancement in most
everely affected myocardial segments (Online Fig. 2) and
y significantly greater vascular density (Fig. 5) and a trend
oward enhanced anti-apoptotic gene expression and re-
uced natriuretic peptide expression in the infarct border
one. Postmortem dual photon microscopic analysis failed
o provide evidence for progenitor cell-mediated car-
iomyogenesis, but confocal analysis clearly demonstrated
ncorporation of genetically labeled EPCs in muscularized
eovessels in the infarct border zone (Fig. 3). Gene expres-
Figure 5 Vascular Density in Infarct Border, Infarct Core, and R
(Top) vascular density was similar between groups in the infarct core or remote m
and MSC (p  0.01). (Bottom) representative lectin-stained sections from the infaion and protein release profiles of cultured progenitor tell populations are consistent with a greater neovascu-
arization potential of autologous late-outgrowth EPCs
ompared with allogeneic MSCs and might hold promise
or novel cell-based strategies to target post-infarction
eart failure.
We compared functional repair capacity of 2 selected
ell-characterized progenitor cell populations in a represen-
ative large animal model of ischemic cardiomyopathy. To
istinguish autocrine versus paracrine effects of infused cells,
e used robust molecular labeling strategies in combination
ith dual photon laser microscopy of the infarct core and
order zones. We did not detect engrafted or transdiffer-
ntiated MSCs 6 weeks after injection in the IRA, consis-
ent with recent reports from several laboratories that have
uggested indirect vasculogenic effects or stimulatory effects
n endogenous resident stem cells (17–19). Loss of plastic-
ty of infused allogeneic MSCs after lentiviral infection or
ultiple in vitro passages or impaired growth factor synthe-
is capacity is unlikely, as evidenced in osteogenic and
dipogenic differentiation assays and secretome analysis.
owever, alternative cell delivery methods, including in-
te Myocardium
ium but significantly higher in the border zone of EPC compared with CON
rder zone of CON (A), EPC (B), and MSC (C). Abbreviations as in Figure 1.emo
yocard
rct boramyocardial injection of MSC or cardiomyogenic pre-
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May 18, 2010:2232–43 Progenitor Cell Repair After Myocardial Infarctionpecification of MSCs before in vivo transfer, might en-
ance their biological repair capacity (20). Of note, we
bserved that IC infusion of 10  106 MSC was associated
ith a transient reduction in epicardial coronary flow, as
easured by MRI, precluding IC injection of higher doses
nd suggesting that direct intramyocardial injection might
e preferable for larger progenitor cells. A similar impedi-
ent in epicardial coronary flow was recently reported in an
pen chest swine model with online near-infrared imaging
21). In contrast, 6 weeks after EPC transfer we observed
ocal areas containing Prussian blue-stained cells lining
mall vessels in the infarct border zone (Fig. 3), suggesting
artial engraftment and survival of EPCs in the border
one. Endorem labeling does not affect tube formation
Figure 6 MMP2 Expression and Collagen Deposition in Infarct
Infarct borders were identified on representative examples of 2,3,5-triphenyltetrazo
EPC (E), matrix metalloproteinase (MMP)-2 immunoreactivity was less pronounced
light microscopy (J to L) suggested a better organized fibrous scar in EPC (K) thanapacity of late outgrowth EPCs on matrigel (data not ghown) but precludes accurate evaluation of in vivo
ngraftment efficiency, because labeling will be lost upon
ell turnover. Therefore, robust genetic labeling with
entiviral LacZ constructs provided proof of concept that
ransferred late-outgrowth EPCs integrate into new
lood vessels.
Because most recent cell-based clinical studies suggest
aracrine trophic mechanisms for the observed changes in
nfarct remodeling or functional recovery (2–4,22,23), we
nvestigated the transcriptome and secretome of both pro-
enitor cell populations. Limited availability of porcine-
pecific gene sequences and commercial antibodies pre-
luded an in-depth analysis of all growth factors operational
n humans. We observed a trend for higher platelet-derived
r
loride stains in CON, EPC, and MSC (A to C, arrowheads). In the border zone of
mpared with CON (D) and MSC (F). After Sirius red staining (G to I), polarized
N (J) and MSC (L). Other abbreviations as in Figure 1.Borde
liumch
as co
in COrowth factor-b transcript levels in EPCs as well as a trend
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Progenitor Cell Repair After Myocardial Infarction May 18, 2010:2232–43or higher angiopoietin-1, hepatocyte growth factor, IGF-1,
GF-2, and VEGF-A transcript levels in MSCs. Of inter-
st, levels of the pro-angiogenic protein PLGF were signif-
cantly and consistently higher in conditioned medium from
PCs compared with MSCs. The latter, in contrast, re-
eased more VEGF and IGF-1, which also play a role in
ngiogenic differentiation pathways. Although protein-
nd gene-based VEGF administration has failed to
nduce therapeutic neovascularization in controlled clinical
rials, PLFG has recently been shown to enhance post-
nfarction myocardial repair and collateral flow development
ia arteriogenesis (24,25). The greater neovascularization po-
ential of EPCs in our study was evidenced by a greater
ascular density in the infarct border zone (Fig. 5) and by a
rend for enhanced myocardial perfusion after MRI contrast
njection. The extent to which greater release of PLGF from
ate outgrowth EPCs is responsible for the observed biological
ffects needs to be determined in specifically designed
ollow-up studies and has significant therapeutic implica-
ions (26).
The observed changes in LV remodeling in EPC-treated
igs suggest that not only absolute infarct size but, more
mportantly, the pattern of infarct healing might be clinically
elevant. Recent clinical MRI studies have also clearly demon-
trated that reduction in infarct transmurality over time deter-
ines LV adverse remodeling, development of heart failure,
nd clinical outcome (27). Animals treated with EPCs develop
ess thinning of infarcted myocardial segments, most likely
ecause of enhanced perfusion and reduced apoptosis in the
nfarct border zone, causing less myocardial strain and infarct
xpansion. Finally, less LV expansion over time in EPC-
reated animals was also consistent with a better-organized
brous scar (Fig. 6) and with reduced MMP2 expression in the
nfarct border (Online Fig. 3).
tudy limitations. We recognize the limitations of repli-
ating clinical conditions in a relatively small set of animals.
lthough we made every effort to use identical cell transfer
nd imaging methodologies as in clinical studies and in-
luded age-matched control pigs treated with IC placebo
njection and a separate series of uninfarcted pigs to account
or growth-related volume changes, the remodeling data
ere obtained after 6 weeks in the absence of beta-blocker
r angiotensin-converting enzyme inhibitor therapy in a
onatherosclerotic background. Also, we only studied a
ingle dose of EPCs and MSCs, which were, however,
reviously determined to be safe and well-tolerated (data
ot shown). Higher doses of MSCs caused intravascular
bstruction (X. Liu, unpublished observations, June 2007).
mportantly, we cannot exclude different results after direct
ntramyocardial injection of MSCs, as demonstrated in
revious porcine studies (28,29). We are unable to compare
ur results with selected CD34-hematopoietic cells, in the
bsence of available selection markers. Finally, follow-up
as limited to 6 weeks after cell transfer, because excessive
eight gain precludes MRI analysis thereafter. Therefore,
e cannot determine whether or not observed benefits inV remodeling mitigate development of overt heart failure
nd increase long-term survival.
onclusions
C transfer of selected progenitor cell populations does not lead
o long-term stable transdifferentiation into competent cardi-
myocytes. Infusion of late-outgrowth EPCs after AMI is
easible and safe and limits maladaptive LV remodeling via
utocrine and paracrine pro-angiogenic effects. Late-
utgrowth EPC transfer might hold promise for heart failure
reatment in patients with ischemic cardiomyopathy.
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